PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol
Background Smoking is the primary preventable risk factor for disease and premature mortality. It is highly addictive and cessation attempts are often unsuccessful. Incentive-based programmes may be an effective method to reach sustained abstinence. Individualisation of incentives based on personal...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e037799.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841556236873498624 |
|---|---|
| author | Alex Burdorf Jasper V Been Frank J Van Lenthe Nienke W Boderie Johannes LW van Kippersluis Diarmaid T Ó Ceallaigh Márta K Radó |
| author_facet | Alex Burdorf Jasper V Been Frank J Van Lenthe Nienke W Boderie Johannes LW van Kippersluis Diarmaid T Ó Ceallaigh Márta K Radó |
| author_sort | Alex Burdorf |
| collection | DOAJ |
| description | Background Smoking is the primary preventable risk factor for disease and premature mortality. It is highly addictive and cessation attempts are often unsuccessful. Incentive-based programmes may be an effective method to reach sustained abstinence. Individualisation of incentives based on personal characteristics yields potential to further increase the effectiveness of incentive-based programmes.Method A randomised controlled trial among healthcare workers recruited through their employer and signed up for a group-based smoking cessation programme. The intervention under study is the provision of personalised incentives on validated smoking cessation at several time points after the smoking cessation programme. A total of 220 participants are required. Participants are randomised 1:1 into intervention (personalised incentives) or control (no incentives). All participants join the group-based programme. Incentives are provided on validated abstinence directly after the smoking cessation programme and after 3, 6 and 12 months.Incentives are provided according to four schemes:(1) Standard: total reward size €350, pay-out scheme: €50 (t=0), €50 (t=3 months), €50 (t=6 months) and €200 (t=12 months), (2) descending: total reward size €300, pay-out scheme: €150, €100, €50 and €0, (3) ascending: total reward size: €400, pay-out scheme: €0, €0, €50 and €350 and (4) deposit: total reward size €450, pay-out scheme: €50, €50, €150, €200; participants pay a €100 deposit, returned conditional on abstinence after 6 months.Advice on which incentive scheme suits participants best is based on willingness to provide a deposit, readiness to quit, nicotine dependency and long-term or short-term reward preference. Participants are free to deviate from this advice. Abstinence is validated at each time point, with 15 months of total follow-up. The primary end point is validated abstinence at 12 months. Effectiveness will be determined by intention-to-treat analysis.Ethics and dissemination The Erasmus MC Medical Ethics Committee decided that according to the Dutch Human Research Law (WMO), the protocol required no formal ethical approval. The results will be published in a peer-reviewed scientific journal and communicated to the participants.Trial registration number Netherlands Trial Register NL7711. |
| format | Article |
| id | doaj-art-995986f410a845ef9ae70f17ad3801f2 |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2020-09-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-995986f410a845ef9ae70f17ad3801f22025-01-07T13:15:12ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2020-037799PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocolAlex Burdorf0Jasper V Been1Frank J Van Lenthe2Nienke W Boderie3Johannes LW van Kippersluis4Diarmaid T Ó Ceallaigh5Márta K Radó61 Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands1 Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The NetherlandsDepartment of Public Health, Erasmus University Medical Center, Rotterdam, NetherlandsDepartment of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The NetherlandsErasmus School of Economics, Erasmus University Rotterdam, Rotterdam, The NetherlandsErasmus School of Economics, Erasmus University Rotterdam, Rotterdam, The NetherlandsDepartment of Paediatrics, Division of Neonatology, Erasmus MC – Sophia Children’s Hospital, University Medical Centre Rotterdam, Rotterdam, The NetherlandsBackground Smoking is the primary preventable risk factor for disease and premature mortality. It is highly addictive and cessation attempts are often unsuccessful. Incentive-based programmes may be an effective method to reach sustained abstinence. Individualisation of incentives based on personal characteristics yields potential to further increase the effectiveness of incentive-based programmes.Method A randomised controlled trial among healthcare workers recruited through their employer and signed up for a group-based smoking cessation programme. The intervention under study is the provision of personalised incentives on validated smoking cessation at several time points after the smoking cessation programme. A total of 220 participants are required. Participants are randomised 1:1 into intervention (personalised incentives) or control (no incentives). All participants join the group-based programme. Incentives are provided on validated abstinence directly after the smoking cessation programme and after 3, 6 and 12 months.Incentives are provided according to four schemes:(1) Standard: total reward size €350, pay-out scheme: €50 (t=0), €50 (t=3 months), €50 (t=6 months) and €200 (t=12 months), (2) descending: total reward size €300, pay-out scheme: €150, €100, €50 and €0, (3) ascending: total reward size: €400, pay-out scheme: €0, €0, €50 and €350 and (4) deposit: total reward size €450, pay-out scheme: €50, €50, €150, €200; participants pay a €100 deposit, returned conditional on abstinence after 6 months.Advice on which incentive scheme suits participants best is based on willingness to provide a deposit, readiness to quit, nicotine dependency and long-term or short-term reward preference. Participants are free to deviate from this advice. Abstinence is validated at each time point, with 15 months of total follow-up. The primary end point is validated abstinence at 12 months. Effectiveness will be determined by intention-to-treat analysis.Ethics and dissemination The Erasmus MC Medical Ethics Committee decided that according to the Dutch Human Research Law (WMO), the protocol required no formal ethical approval. The results will be published in a peer-reviewed scientific journal and communicated to the participants.Trial registration number Netherlands Trial Register NL7711.https://bmjopen.bmj.com/content/10/9/e037799.full |
| spellingShingle | Alex Burdorf Jasper V Been Frank J Van Lenthe Nienke W Boderie Johannes LW van Kippersluis Diarmaid T Ó Ceallaigh Márta K Radó PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol BMJ Open |
| title | PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol |
| title_full | PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol |
| title_fullStr | PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol |
| title_full_unstemmed | PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol |
| title_short | PERSonalised Incentives for Supporting Tobacco cessation (PERSIST) among healthcare employees: a randomised controlled trial protocol |
| title_sort | personalised incentives for supporting tobacco cessation persist among healthcare employees a randomised controlled trial protocol |
| url | https://bmjopen.bmj.com/content/10/9/e037799.full |
| work_keys_str_mv | AT alexburdorf personalisedincentivesforsupportingtobaccocessationpersistamonghealthcareemployeesarandomisedcontrolledtrialprotocol AT jaspervbeen personalisedincentivesforsupportingtobaccocessationpersistamonghealthcareemployeesarandomisedcontrolledtrialprotocol AT frankjvanlenthe personalisedincentivesforsupportingtobaccocessationpersistamonghealthcareemployeesarandomisedcontrolledtrialprotocol AT nienkewboderie personalisedincentivesforsupportingtobaccocessationpersistamonghealthcareemployeesarandomisedcontrolledtrialprotocol AT johanneslwvankippersluis personalisedincentivesforsupportingtobaccocessationpersistamonghealthcareemployeesarandomisedcontrolledtrialprotocol AT diarmaidtoceallaigh personalisedincentivesforsupportingtobaccocessationpersistamonghealthcareemployeesarandomisedcontrolledtrialprotocol AT martakrado personalisedincentivesforsupportingtobaccocessationpersistamonghealthcareemployeesarandomisedcontrolledtrialprotocol |